Norisodrine

NDA 6905, held by Abbvie. Isoproterenol Sulfate.

As of Nov 14, 2026, NDA 6905 (Norisodrine), held by Abbvie, was not approved, with 6 approved supplements and 0 published complete response letters.

First approved: Not approved
Supplements approved: 6
Complete response letters: 0

Products

2 strengths and forms


Norisodrine25% · powder;inhalation	Isoproterenol Sulfate	Discontinued
Norisodrine10% · powder;inhalation	Isoproterenol Sulfate	Discontinued

All 6 submissions, including labeling and manufacturing supplements


Oct 29, 1983	Supplement 10Manufacturing · Standard review	Approved	None posted
Oct 29, 1983	Supplement 11Labeling	Approved	None posted
Jan 19, 1982	Supplement 7Manufacturing · Standard review	Approved	None posted
Jan 29, 1981	Supplement 6Manufacturing · Standard review	Approved	None posted
Feb 3, 1976	Supplement 5Labeling	Approved	None posted
Jun 25, 1975	Supplement 2Manufacturing · Standard review	Approved	None posted

Identifiers

Application: NDA 6905
Drugs@FDA: Overview at FDA
Company: AbbVie

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters